Webinar: Rapid, comprehensive AAV genomic profiling made simple

As the field of gene therapy advances, the need for fast, accurate, and scalable characterisation of adeno-associated virus (AAV) products and the plasmids used to produce them has never been greater.

Hear Oxford Nanopore Technologies and Plasmidsaurus present an expert-led webinar showcasing new and improved genomics solutions for gene therapy development and vector quality control. Throughout the session, you’ll hear real-world case studies where gene therapy teams have applied this solution to characterise vector impurities, resolve historically challenging DNA motifs such as inverted terminal repeats (ITRs), and accelerate vector development.

This session introduces an updated sequencing workflow that delivers deeper insights into AAV products, helping to identify and clarify critical quality attributes often missed by alternative sequencing methods, and providing results in just days, not weeks.